{"id":"CHEMBL1003","canonicalSmiles":"O=C([O-])[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21.[K+]","inchiKey":"ABVRVIZBZKUTMK-JSYANWSFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAVULANATE POTASSIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL777","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BRL 14151K","BRL-14151K","Clavulanate potassium","Potassium clavulanate"],"crossReferences":{"DailyMed":["clavulanate%20potassium"],"chEBI":["85264"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 6 approved and 6 investigational indications."}
{"id":"CHEMBL1043","canonicalSmiles":"Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1","inchiKey":"MQJKPEGWNLWLTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPSONE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aczone","Dapsone"],"synonyms":["Dapsone","Dapsonum","Diaminodiphenylsulfone","Diaphenylsulfone","J04BA02","NSC-6091","NSC-6091D","Novophone","Servidapson"],"crossReferences":{"DailyMed":["dapsone"],"PubChem":["11112211","124882059","144203922","144208545","144210875","170464895","17389950","26747072","49718182","855979"],"Wikipedia":["Dapsone"],"drugbank":["DB00250"],"chEBI":["4325"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 3 approved and 14 investigational indications."}
{"id":"CHEMBL105720","canonicalSmiles":"CSC[S@+]([O-])C[C@H](CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O","inchiKey":"XKLZIVIOZDNKEQ-CLQLPEFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL105720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04222"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1090488","canonicalSmiles":"C[C@H]1CN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)C[C@@H](C)[C@]1(O)c1ccccc1","inchiKey":"WHPJOAUPIZDJNX-AGGGUQDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00446687","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-PF-00446687","Pf-00446687"],"crossReferences":{"drugbank":["DB12517"]},"childChemblIds":["CHEMBL1204059"],"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","EFO_0004234"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL112953","canonicalSmiles":"C#CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)nc(F)nc21","inchiKey":"KCIOVTSUEXGUFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL112953","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02550"],"chEBI":["47628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161253","canonicalSmiles":"N=C(N)c1cccc(C[C@H](NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCC[C@@H]2C(=O)O)c1","inchiKey":"GNANSBQAIRJZPA-XZOQPEGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161253","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04238"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200340","canonicalSmiles":"CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O","inchiKey":"PGZUMBJQJWIWGJ-ONAKXNSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSELTAMIVIR PHOSPHATE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1229","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oseltamivir phosphate","Tamiflu"],"synonyms":["Agucort","Oseltamivir (as phosphate)","Oseltamivir phosphate","Oseltamiviri phosphas","RO 64-0796/002","RO-64-0796-002"],"crossReferences":{"DailyMed":["oseltamivir%20phosphate"],"chEBI":["7799"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for chronic kidney disease and influenza and has 1 investigational indication."}
{"id":"CHEMBL1200584","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.[K+]","inchiKey":"PRZJIMSXCLZGLT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOSALICYLATE POTASSIUM","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paskalium","Potassium aminosalicylate"],"synonyms":["Aminosalicylate potassium","Potassium aminosalicylate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955."}
{"id":"CHEMBL1200647","canonicalSmiles":"CC1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)CC(O)C(C(=O)O)C(O)CC(=O)CC(O)CC(O)CC(O)CC(=O)CCCC(=O)CC(=O)OC1C(C)CC(C)C(O)CC(=O)c1ccc(N)cc1","inchiKey":"OPGSFDUODIJJGF-JBUZINEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDICIDIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vanobid"],"synonyms":["Candicidin"],"crossReferences":{"Wikipedia":["Candicidin"],"drugbank":["DB01152"],"chEBI":["3349"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200671","canonicalSmiles":"CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"FUCZIEGYURIPAY-CFWZQLQRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NAFARELIN ACETATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201309","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Synarel"],"synonyms":["Nafarelin acetate","Nafarelin acetate anhydrous","Nafarelin acetate hydrate","Nasanyl","RS-94991","RS-94991-298"],"crossReferences":{"DailyMed":["nafarelin%20acetate"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0001065"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for endometriosis."}
{"id":"CHEMBL1200715","canonicalSmiles":"CC(CNC1CCCCC1)OC(=O)c1ccccc1.Cl","inchiKey":"MTFCPNHRBINLRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXYLCAINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1197","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyclaine"],"synonyms":["Hexylcaine HCl","Hexylcaine hcl","Hexylcaine hydrochloride"],"crossReferences":{"PubChem":["144204007","170465088","56463225"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200769","canonicalSmiles":"CN(C)CCN(Cc1ccccc1)c1ccccn1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"GGRBYIUPUOYRLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPELENNAMINE CITRATE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-757360","Tripelennamine citrate"],"crossReferences":{"PubChem":["144205071","170465118","26749792"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948."}
{"id":"CHEMBL1200963","canonicalSmiles":"CCNC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1","inchiKey":"AQOKCDNYWBIDND-FTOWTWDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMATOPROST","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bimatoprost","Durysta","Latisse","Lumigan"],"synonyms":["AGN 192024","AGN-192024","Bimatoprost","Prostamide"],"crossReferences":{"DailyMed":["bimatoprost"],"Wikipedia":["Bimatoprost"],"drugbank":["DB00905"],"chEBI":["51230"]},"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["HP_0010750","EFO_0004190","EFO_1001069","EFO_1001022","EFO_0004192","Orphanet_79364","MONDO_0005129","EFO_1001466","Orphanet_55654","EFO_0004208","EFO_0000516","EFO_0004191","MONDO_0003037"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 5 approved and 4 investigational indications."}
{"id":"CHEMBL1201083","canonicalSmiles":"[123I-].[Na+]","inchiKey":"FVAUCKIRQBBSSJ-VVUPZWBASA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM IODIDE I 123","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1644695","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sodium iodide i 123"],"synonyms":["Sodium Iodide (123I)","Sodium iodide (123 i)","Sodium iodide (123i)","Sodium iodide (123i) capsules","Sodium iodide i 123","Sodium iodide i-123","Sodium iodide i123","Sodium iodide, i-123","Sodium iodide,i-123","Sodium iodide-123"],"crossReferences":{"DailyMed":["sodium%20iodide%20i-123"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for hyperthyroidism and thyroid carcinoma."}
{"id":"CHEMBL1201152","canonicalSmiles":"C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl","inchiKey":"GYWMRGWFQPSQLK-OPHZJPRHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALMEFENE HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL982","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revex"],"synonyms":["JF-1 HYDROCHLORIDE","Nalmefene hcl","Nalmefene hydrochloride"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["MONDO_0007079"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and has 1 investigational indication."}
{"id":"CHEMBL1201204","canonicalSmiles":"Cc1cc(O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)cn1","inchiKey":"PWAUCHMQEXVFJR-PMAPCBKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPIRAMIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefpiramide","NSC-759869","WY-44,635","WY-44635"],"crossReferences":{"PubChem":["144206001","50112698"],"Wikipedia":["Cefpiramide"],"drugbank":["DB00430"],"chEBI":["59213"]},"childChemblIds":["CHEMBL1200672"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for bacterial disease."}
{"id":"CHEMBL1201265","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12","inchiKey":"IMBXEJJVJRTNOW-XYMSELFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE HEMISUCCINATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methylprednisolone hemisuccinate","Methylprednisolone succinate"],"crossReferences":{"DailyMed":["methylprednisolone%20sodium%20succinate"],"PubChem":["124896649"],"drugbank":["DB14644"]},"childChemblIds":["CHEMBL1201081"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001222","EFO_0000275","EFO_0004228","EFO_0003778","EFO_0001379","EFO_0009267","EFO_0005952","MONDO_0002462","EFO_0000540","EFO_0000565","EFO_0000474","MONDO_0002471","EFO_0002690","MONDO_0002280","EFO_0003884","EFO_0004616","Orphanet_700","EFO_0004143","EFO_0007332","EFO_0005140","EFO_0008522","EFO_1001272","EFO_0000198","MONDO_0013730","EFO_0000694","EFO_0000685","EFO_0000220","Orphanet_701","EFO_0007537","EFO_1001466","EFO_0000222","EFO_0003929","EFO_0004194","EFO_0003894","EFO_0004599","EFO_0003843","EFO_1001119","EFO_0002609","EFO_0003106","HP_0100806","MP_0001845","EFO_0003840","MONDO_0100096","MONDO_0005301","EFO_0000095","EFO_0007359","MONDO_0002406","EFO_0000574","MONDO_0004979","EFO_0001378","EFO_0000341","EFO_0003918","MONDO_0005178","EFO_0001063"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 16 approved and 25 investigational indications."}
{"id":"CHEMBL1201275","canonicalSmiles":"CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(S(=O)(=O)[O-])ccc2S(=O)(=O)O)cc1","inchiKey":"YFKDCGWIINMRQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOSULFAN BLUE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["isosulfan%20blue"]},"childChemblIds":["CHEMBL1200859"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1981 and has 1 investigational indication."}
{"id":"CHEMBL1201345","canonicalSmiles":"CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)O","inchiKey":"GROJOWHVXQYQGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRADECYL SULFURIC ACID","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tetradecyl sulfate"],"crossReferences":{"DailyMed":["sodium%20tetradecyl%20sulfate"],"PubChem":["29218059"],"drugbank":["DB11328"],"chEBI":["75275"]},"childChemblIds":["CHEMBL1200354"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and is indicated for varicose veins and has 1 investigational indication."}
{"id":"CHEMBL1201419","drugType":"Protein","blackBoxWarning":false,"name":"LUTROPIN ALFA","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Luveris"],"synonyms":["ATC G03 GA GONADOTROPINS","Luteinising hormone","Luteinising hormone (human)","Lutropin alfa"],"crossReferences":{"DrugCentral":["4929"]},"linkedTargets":{"rows":["ENSG00000138039"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_0008560","MONDO_0018555"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 investigational indications."}
{"id":"CHEMBL1201659","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENIRAMINE POLISTIREX","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL505","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorpheniramine polistirex"],"crossReferences":{"DailyMed":["chlorpheniramine%20polistirex"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL1201717","drugType":"Protein","blackBoxWarning":false,"name":"MECASERMIN RINFABATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iplex","Somatokine"],"synonyms":["Mecasermin Rinfabate Recombinant","Mecasermin rinfabate","Mecasermin rinfabate recombinant","RHIGF-I/RHIGFBP-3"],"crossReferences":{"DrugCentral":["5197"]},"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["Orphanet_206647","Orphanet_633","Orphanet_273","EFO_1001158"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 4 investigational indications."}
{"id":"CHEMBL1213371","canonicalSmiles":"O=C(O)c1cccc(/C=N/OCCO/N=C/c2cc(=O)[nH]c(=O)[nH]2)c1","inchiKey":"TUYDQQMKXSQIQG-GONBZBRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213371","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07760"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL122270","canonicalSmiles":"CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1","inchiKey":"MXYUKLILVYORSK-HBMCJLEFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBELINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Lobeline",".alpha.-lobeline","Alpha-Lobeline","Alpha-Lobeline HCl","Inflatine","Lobeline","Lobeline hydrochloride","Lobelinum","NSC-757421"],"crossReferences":{"PubChem":["144204451","26751618","29215024","50104285","90340738"],"drugbank":["DB05137"],"chEBI":["48723"]},"childChemblIds":["CHEMBL1257005"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1230065","canonicalSmiles":"CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C","inchiKey":"GDTQLZHHDRRBEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-582949","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-582949","Bms 582949","Bms-582949","PS-540446","Ps-540446"],"crossReferences":{"drugbank":["DB12696"]},"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000676","EFO_0004264"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1232157","canonicalSmiles":"CCCCCCCCCC[N+](C)(C)[O-]","inchiKey":"ZRKZFNZPJKEWPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212550"],"drugbank":["DB02613"],"chEBI":["41899"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237102","canonicalSmiles":"C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1.Cl","inchiKey":"OICFWWJHIMKBCD-VALQNVSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOCABASTINE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1615438","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Livostin"],"synonyms":["Levocabastine hcl","Levocabastine hydrochloride","R 50,547","R-50547"],"crossReferences":{"PubChem":["144204246","170465061","56463149"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_1001417"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993 and has 1 investigational indication."}
{"id":"CHEMBL1256994","canonicalSmiles":"C[N+](C)(C)CCOP(=O)([O-])OP(=O)([O-])OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O.[Na+]","inchiKey":"YWAFNFGRBBBSPD-OCMLZEEQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CITICOLINE SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1231700","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ceraxon"],"synonyms":["Cdp-cholin","Citicoline","Citicoline sodium","Citicoline sodium salt","IP 302 SODIUM","IP-302 SODIUM"],"crossReferences":{"PubChem":["144206990","855585"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL129529","canonicalSmiles":"CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1","inchiKey":"HQFWVSGBVLEQGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTACAINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butacaine","NSC-758632"],"crossReferences":{"PubChem":["11112305","124882226","144203979","170465459","26747049","855942"],"drugbank":["DB11502"]},"childChemblIds":["CHEMBL3142544"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL135287","canonicalSmiles":"CC1=C(CCCCCC(=O)O)C(=O)c2ccccc2C1=O","inchiKey":"ICGRXHWXPCXIKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL135287","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1364144","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"PLBHSZGDDKCEHR-LFYFAGGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE ACETATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Depmedalone","Depo-medrol","Depo-medrone","M-predrol","Medrol","Medrol acetate","Methylprednisolone acetate","Neo-medrone"],"synonyms":["Methyl prednisolone acetate","Methylprednisolone 21-acetate","Methylprednisolone acetate","NSC-48985"],"crossReferences":{"DailyMed":["methylprednisolone%20acetate"],"PubChem":["144205275","50085428"],"chEBI":["6889"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001222","EFO_1001896","EFO_0007405","EFO_1001178","EFO_0004274","MONDO_0002041","MONDO_0003541","EFO_1001909","EFO_0000565","MONDO_0005277","EFO_1000653","MONDO_0002280","MONDO_0002471","EFO_0004255","EFO_0004616","EFO_0004143","HP_0003419","EFO_0005762","EFO_0000685","HP_0012532","EFO_0003843","EFO_1000941","EFO_1001231","MONDO_0002406","EFO_0000574","MONDO_0004979","EFO_0003833","MONDO_0005178","MONDO_0004857"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 13 approved and 8 investigational indications."}
{"id":"CHEMBL1407356","canonicalSmiles":"CC(=O)N1C[C@H](O)C[C@H]1C(=O)O","inchiKey":"BAPRUDZDYCKSOQ-RITPCOANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXACEPROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetyl hydroxyproline","Jonctum","Oxaceprol"],"crossReferences":{"PubChem":["144205705","170466355","57264330"],"drugbank":["DB13363"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL140830","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CN","inchiKey":"VJTPBNUXDULDQD-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL140830","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04227"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1475252","canonicalSmiles":"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2n1","inchiKey":"ZBFDAUIVDSSISP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENATOPRAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TU-199","TU199","Tenatoprazole"],"crossReferences":{"PubChem":["144206071","170465931","50112774"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL153585","canonicalSmiles":"CC(C)NCC(O)COc1cccc2c1C=CC2","inchiKey":"MPGBPFMOOXKQRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDENOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indenolol","Indenolol hydrochloride","SCH 28316Z","SCH-28316Z"],"crossReferences":{"DrugCentral":["1436"],"drugbank":["DB08952"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1583","canonicalSmiles":"CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C","inchiKey":"PFOLLRNADZZWEX-FFGRCDKISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BACAMPICILLIN","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bacampicillin","Penglobe"],"crossReferences":{"Wikipedia":["Bacampicillin"],"drugbank":["DB01602"],"chEBI":["2968"]},"childChemblIds":["CHEMBL1200965"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1628233","canonicalSmiles":"O=C([O-])c1ccccc1-c1c2ccc(=O)cc-2oc2cc([O-])ccc12.[Na+].[Na+]","inchiKey":"NJDNXYGOVLYJHP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORESCEIN SODIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4297067","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ak-Fluor","Fluor-amps","Fluorescite","Fluorets","Funduscein","Funduscein-25","Retinofluor"],"synonyms":["Acid yellow 73 sodium salt","C.i. 45350","C.i. acid yellow 73","Ci 45350","Fluorescein disodium salt","Fluorescein sodium","Fluorescein, disodium salt","Fluorescein, soluble","Fluoresceinum natricum","Ki202","Ki202(1)","Ki202(2)","Resorcinol phthalein sodium","Soluble fluorescein","Uranin","Uranine","Uranine wss","Yellow 8"],"crossReferences":{"DailyMed":["fluorescein%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 5 investigational indications."}
{"id":"CHEMBL1650443","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O","inchiKey":"IWYJYHUNXVAVAA-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRELAGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SYR-472","Trelagliptin"],"crossReferences":{"drugbank":["DB15323"]},"childChemblIds":["CHEMBL1650457","CHEMBL2105754","CHEMBL1650456"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0000400","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1764","canonicalSmiles":"COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2","inchiKey":"VRQVVMDWGGWHTJ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMEPROMAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levomepromazine","Levoprome","Nirvan","Tisercin"],"synonyms":["CL 36467","CL 39743","CL-36467","CL-39743","Levomepromazine","Methotrimeprazine","N05AA02","NSC-226516","Neozine","Nirvan","RP 7044","RP-7044","SK&F 5116","SK&F-5116","XP-03","XP03"],"crossReferences":{"Wikipedia":["Levomepromazine"],"drugbank":["DB01403"],"chEBI":["6838"]},"childChemblIds":["CHEMBL2104973","CHEMBL1725730"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL1794791","canonicalSmiles":"O=C(O)CC(=O)C(=O)O","inchiKey":"KHPXUQMNIQBQEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXALOACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anhydrous enol-oxaloacetate","Bioepg","NSC-77688","Oxaloacetate","Oxaloacetic acid","Oxosuccinic acid"],"crossReferences":{"PubChem":["144208413"],"chEBI":["30744"]},"childChemblIds":["CHEMBL3950828"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1908397","canonicalSmiles":"O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1","inchiKey":"YYLKKYCXAOBSRM-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KW-2449","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KW-2449","Kw 2449","Kw-2449"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000097007","ENSG00000178999","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1922235","canonicalSmiles":"COc1ccc(C(=O)Nc2cccc(O)c2NC(=O)c2ccc(N3CCCN(C)CC3)cc2)cc1","inchiKey":"IJNIQYINMSGIPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAREXABAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darexaban","Tanexaban","YM-150","YM150"],"crossReferences":{"drugbank":["DB12289"]},"childChemblIds":["CHEMBL1922345","CHEMBL3527359"],"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0000275","EFO_0004286","EFO_0005672"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL200177","canonicalSmiles":"CCn1ncnc1COc1nn2c(-c3ccccc3F)nnc2cc1C(C)(C)C","inchiKey":"QKIWQBLNTSQOLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0777","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK0777","Mk-0777","Mk0777","TPA-023","TPA023"],"crossReferences":{"drugbank":["DB12238"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2019090","canonicalSmiles":"CCc1c(C)cc(C(=O)NC2(C(=O)O)CCCCC2)c(=O)n1Cc1ccc(F)cc1","inchiKey":"JIYXOJFSPOFZPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-777469","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-777469"],"linkedTargets":{"rows":["ENSG00000188822"],"count":1},"linkedDiseases":{"rows":["EFO_0000274"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2096634","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM CHROMATE CR 51","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110574","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chromitope sodium","Rachromate","Sodium chromate cr 51"],"synonyms":["51cr","Sodium chromate (51 cr)","Sodium chromate (51cr)","Sodium chromate (51cr) injection","Sodium chromate cr 51","Sodium chromate cr-51","Sodium chromate cr51","Sodium chromate, cr-51","Sodium chromate,cr-51","Sodium radiochromate"],"crossReferences":{"DrugCentral":["5106"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2103794","canonicalSmiles":"CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1.Cl","inchiKey":"VFYAEUWJFGTGGO-GHTUPXNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAMORELIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110579","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anamorelin hcl","Anamorelin hydrochloride","Ono-7643","RC-1291 HCl"],"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","HP_0004326","HP_0012378"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103959","canonicalSmiles":"C[C@H]1O[C@@H](O[C@H]2[C@@H](OC=O)C[C@H](O[C@H]3[C@@H](OC=O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)[C@@H](OC=O)C[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](OC=O)[C@@H]1OC=O","inchiKey":"DOMHWKQEPDYUQX-LJAQBGIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GITOFORMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC 2770","AC-2770","Formiloxin","Formiloxine","Gitoformate","Gitoxin, pentaformate","Pentaformylgitoxin"],"crossReferences":{"drugbank":["DB13537"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104449","canonicalSmiles":"CC(=O)N(O)CC1=C(n2ccccc2=O)c2cc(C(F)(F)F)ccc2OC1(C)C","inchiKey":"FXRJKZVWFJSKGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARAKALIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RS-91309","Sarakalim"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104783","canonicalSmiles":"COCC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"IUNJANQVIJDFTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOPENTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPD-5411","CPD. 5411","Iodixanol related compound d","Iopentol"],"crossReferences":{"drugbank":["DB13861"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106471","canonicalSmiles":"OCC1COC(CI)O1","inchiKey":"NEIPZWZQHXCYDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMIODOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Domiodol","M.G. 13608","MG-13608"],"crossReferences":{"drugbank":["DB13768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107386","canonicalSmiles":"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1.O=S(=O)(O)O","inchiKey":"NQRYCIGCIAWEIC-CKLVGUEFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORAPAXAR SULFATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL493982","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zontivity"],"synonyms":["SCH 530348","SCH-530348","Vorapaxar sulfate"],"crossReferences":{"DailyMed":["vorapaxar%20sulfate"],"chEBI":["83314"]},"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0000712","EFO_0000612","EFO_0005672","EFO_0004265"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107880","drugType":"Antibody","blackBoxWarning":false,"name":"REGAVIRUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCA-C23","Regavirumab","TI-23"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108015","drugType":"Unknown","blackBoxWarning":false,"name":"VITAMIN B COMPLEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Becotin","Becozym","Betalin complex","Betalin compound"],"synonyms":["Vitamin b complex"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108627","drugType":"Gene","blackBoxWarning":false,"name":"VOCIMAGENE AMIRETROREPVEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TOCA 511","TOCA-511","Vocimagene amiretrorepvec"],"description":"Gene drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108658","drugType":"Antibody","blackBoxWarning":false,"name":"TREMELIMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-675,206","CP-675206","PF-06753388","TICILIMUMAB","Ticilimumab","Tremelimumab","Tremelimumab (genetical recombination)"],"linkedTargets":{"rows":["ENSG00000163599"],"count":1},"linkedDiseases":{"rows":["EFO_0003891","EFO_0000365","EFO_0001075","MONDO_0003890","EFO_0000756","EFO_0000681","MONDO_0044704","EFO_1001951","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0008528","EFO_0000501","EFO_0000641","EFO_0000514","MONDO_0003001","EFO_0000198","EFO_0002618","EFO_0001642","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_1001968","EFO_0005221","MONDO_0008315","EFO_1001100","EFO_0004284","EFO_0000574","EFO_0006544","EFO_0001378","MONDO_0015686","MONDO_0007254","EFO_0000708","EFO_0000305","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_1000044","EFO_0000673","EFO_0002617","EFO_0000616","EFO_0005220","MONDO_0021656","EFO_1000616","EFO_0000503","EFO_0000478","EFO_0000403","MONDO_0003002","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_0000311","EFO_1001961","EFO_0003863","MONDO_0021148","EFO_0000764","EFO_0002517","EFO_0000702","EFO_0000199","EFO_0004142","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0000519"],"count":67},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 58 investigational indications."}
{"id":"CHEMBL2109171","drugType":"Protein","blackBoxWarning":false,"name":"DIBOTERMIN ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dibotermin","Dibotermin alfa","Inductos","Nebotermin","Rhbmp-2"],"crossReferences":{"DrugCentral":["5024"]},"description":"Protein drug with a maximum clinical trial phase of IV and is indicated for bone disease."}
{"id":"CHEMBL2109303","drugType":"Antibody","blackBoxWarning":false,"name":"AVP-21D9","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVP-21D9","AVP21D9","Avp-21d9"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109322","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-820","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-820","Amg-820"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003060","EFO_1001951","EFO_0000311"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109458","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-108","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-108","Amg-108"],"linkedTargets":{"rows":["ENSG00000115594"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000400","MONDO_0005178"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110781","canonicalSmiles":"Cc1ccccc1CN1CCN(CCOC(c2ccccc2)c2ccccc2Cl)CC1","inchiKey":"VEVSKUJZSMGTMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORBENZOXAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorbenzoxamine"],"crossReferences":{"drugbank":["DB13788"]},"childChemblIds":["CHEMBL3989550"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111112","canonicalSmiles":"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC","inchiKey":"VBHQKCBVWWUUKN-KZNAEPCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERNAKALANT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vernakalant"],"crossReferences":{"drugbank":["DB06217"]},"childChemblIds":["CHEMBL2107383"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000055118","ENSG00000162989","ENSG00000130037","ENSG00000120457","ENSG00000171385"],"count":6},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275","EFO_0004269"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiac arrhythmia and has 3 investigational indications."}
{"id":"CHEMBL2165615","canonicalSmiles":"Cc1cnc(NC(=O)c2cc(Oc3cnc(C(=O)N(C)C)nc3)c3cc(C)oc3c2)cn1","inchiKey":"MASKQITXHVYVFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04937319","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04937319","Pf-04937319"],"crossReferences":{"drugbank":["DB15009"]},"linkedTargets":{"rows":["ENSG00000106633"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2220486","canonicalSmiles":"CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12","inchiKey":"CUDVHEFYRIWYQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCITANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-3810","Al-3810","CO-3810","E-3810","Lucitanib","S 80881","S-80881"],"crossReferences":{"drugbank":["DB11845"],"chEBI":["65209"]},"childChemblIds":["CHEMBL2180605"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000066468","ENSG00000102755","ENSG00000077782","ENSG00000037280"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0021148","MONDO_0007254","EFO_0000702","EFO_0003060","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL225071","canonicalSmiles":"Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1","inchiKey":"IVTVGDXNLFLDRM-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALTITREXED","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tomudex"],"synonyms":["Raltitrexed","ZD-16","ZD-1694","ZD1694"],"crossReferences":{"PubChem":["144205790","144207198","49681782","499545"],"Wikipedia":["Raltitrexed"],"drugbank":["DB00293"],"chEBI":["5847"]},"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0005922","EFO_0000365","EFO_1000657","EFO_0005842","MONDO_0007576","MONDO_0000870","EFO_0004252","EFO_1001951","EFO_1000123","MONDO_0001056","EFO_1001480","EFO_0000588","EFO_0000182","EFO_0000330","EFO_0000707","EFO_0000181"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 12 investigational indications."}
{"id":"CHEMBL235191","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1","inchiKey":"VAZAPHZUAVEOMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACEDINALINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-994","GOE 5549","GOE-5549","PD 123654","PD-123654","Tacedinaline"],"crossReferences":{"drugbank":["DB12291"],"chEBI":["90195"]},"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000068024","ENSG00000147099","ENSG00000116478","ENSG00000163517","ENSG00000100429","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0008903","EFO_0001378"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL237337","canonicalSmiles":"CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1","inchiKey":"ZNHVIJAGMFQGMS-IHPCNDPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237337","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08504"]},"childChemblIds":["CHEMBL377221"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2396661","canonicalSmiles":"Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1","inchiKey":"STUWGJZDJHPWGZ-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPELISIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Piqray"],"synonyms":["Alpelisib","BYL-719","BYL719","Byl-719","NVP-BYL719"],"crossReferences":{"DailyMed":["alpelisib"],"drugbank":["DB12015"]},"linkedTargets":{"rows":["ENSG00000121879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_1001931","EFO_0003869","EFO_0005922","EFO_1000616","EFO_0000186","MONDO_0008170","Orphanet_44890","MONDO_0007254","EFO_1000657","EFO_0000305","MONDO_0044704","EFO_1001951","EFO_0000311","MONDO_0001056","EFO_1001480","MONDO_0011962","EFO_0004284","EFO_0009146","EFO_0001421","EFO_0001378","Orphanet_2495","EFO_0000707","EFO_0000181"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 5 approved and 15 investigational indications."}
{"id":"CHEMBL244243","canonicalSmiles":"C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1cccc(C(F)(F)F)c1","inchiKey":"ZPKHVQNRKMCYGL-AFAPVMNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SRX246","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Srx246"],"linkedTargets":{"rows":["ENSG00000166148"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0004247","EFO_0001358","EFO_0005230"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL248176","canonicalSmiles":"CCNC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1","inchiKey":"ARMFMDYRYOKSOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL248176","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08005"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253359","canonicalSmiles":"Cc1cc(-c2nc3ccccc3o2)cc(C)c1O","inchiKey":"NORYHCMDDBZXDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253359","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258202","canonicalSmiles":"CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1","inchiKey":"OYOUIHFZUAKCEF-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-640994","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-640994"],"crossReferences":{"drugbank":["DB06991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260629","canonicalSmiles":"N=C(NO)NCCC[C@H](N)C(=O)O","inchiKey":"FQWRAVYMZULPNK-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL260629","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111278"],"drugbank":["DB03144"],"chEBI":["43088"]},"childChemblIds":["CHEMBL1256282"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273158","canonicalSmiles":"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1","inchiKey":"FOHZGCHKLPIBBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL273158","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL294199","canonicalSmiles":"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O","inchiKey":"YKPUWZUDDOIDPM-SOFGYWHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPSAICIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Qutenza","Zacin","Zostrix","Zostrix hp"],"synonyms":["ALGRX 4975","ALGRX-4975","Ausanil","Axsain","Capsaicin","Capzasin-hp","Cntx-4975","Dolenon","FEMA NO. 3404","Mioton","NGX-1998","NGX-4010","NSC-56353","Ngx-1998","Ovocap","Ratden pe 40","Togarashi orenji","Trans-capsaicin"],"crossReferences":{"DailyMed":["capsaicin"],"PubChem":["104171351","124883045","124883047","124883049","124883050","124890089","144204368","144207513","17389996","26747263","26752818","26752819","26752820","50105473","56463572"],"Wikipedia":["Capsaicin"],"drugbank":["DB06774"],"chEBI":["3374"]},"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_1001896","EFO_0001361","HP_0000989","MONDO_0001583","MONDO_0041052","HP_0012735","MONDO_0007254","EFO_0003913","Orphanet_213","HP_0002829","EFO_1000783","MONDO_0005277","EFO_0009430","EFO_0009582","EFO_0000712","EFO_0009619","EFO_0000676","EFO_0004616","EFO_0006510","HP_0002013","MONDO_0004976","EFO_1000850","EFO_0009625","EFO_0005762","EFO_0005854","EFO_0008521","EFO_0006859","EFO_0006911","EFO_0005856","HP_0003418","EFO_0009387","EFO_1001054","HP_0003394","EFO_0003843","EFO_1000941","MONDO_0008315","HP_0003326","EFO_0009364","EFO_0000764","MONDO_0043510","MONDO_0005178","EFO_1001434"],"count":42},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 12 approved and 23 investigational indications."}
{"id":"CHEMBL3","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1","inchiKey":"SNICXCGAKADSCV-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Habitrol","Nicabate","Nicoderm","Nicoderm cq","Nicopass","Nicopatch","Nicorette invisi","Nicotine","Nicotinell classic","Nicotinell support","Nicotinell tts 10","Nicotinell tts 20","Nicotinell tts 30","Nicotrol","Nicotrol Inhaler","Nicotrol NS","Niquitin","Niquitin clr","Niquitin minis cherry","Niquitin minis mint","Niquitin minis orange","Niquitin mint","Niquitin pre-quit","Niquitin strips mint","Prostep","Stoppers","Stubit"],"synonyms":["Nicotine"],"crossReferences":{"DailyMed":["nicotine"],"PubChem":["144209012","144210494","17389805","26752744","26752745","26752746","50105392","50105393","56314824","90341453"],"Wikipedia":["Nicotine"],"drugbank":["DB00184"],"chEBI":["17688"]},"childChemblIds":["CHEMBL3137669","CHEMBL1448280","CHEMBL3989563","CHEMBL3182465","CHEMBL151515","CHEMBL225057","CHEMBL1201536"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["MONDO_0004938","MONDO_0005090","EFO_0002610","MONDO_0002009","DOID_13406","MONDO_0007254","MONDO_0004567","EFO_0003768","EFO_1001461","EFO_0004318","EFO_0007191","HP_0100543","MONDO_0002050","MONDO_0002974","MONDO_0005180","MONDO_0008903","EFO_0003144","MONDO_0007079","MONDO_0004647","Orphanet_797","EFO_0000694","EFO_0004319","EFO_0003888","EFO_0004329","EFO_0001645","Orphanet_3389","EFO_0000313","EFO_0003843","EFO_0000546","GO_0007568","EFO_0001072","MP_0001845","MONDO_0100096","MONDO_0004975","EFO_0004888","EFO_0000341","HP_0000678","MONDO_0005148","EFO_0005411","EFO_0000691","EFO_0005672"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for nicotine dependence and has 26 investigational indications."}
{"id":"CHEMBL3133037","canonicalSmiles":"Cc1c(Cc2ccccc2)nnc(N2CCN(c3cnc(C(C)(C)O)cn3)[C@H](C)C2)c1C","inchiKey":"POERAARDVFVDLO-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEQ506","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LEQ-506","LEQ506","Leq 506","Leq506","NVP-LEQ506","Nvp-leq-506"],"crossReferences":{"drugbank":["DB12857"]},"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0002939","EFO_0004193"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3186422","canonicalSmiles":"CCCCCC[C@@H](O)C/C=C\\CCCCCCCC(=O)O","inchiKey":"WBHHMMIMDMUBKC-QJWNTBNXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186422","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206956","144211415"],"drugbank":["DB02955"],"chEBI":["28592"]},"childChemblIds":["CHEMBL3186755"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301601","canonicalSmiles":"CN1C(=N)N[C@](C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O","inchiKey":"YHYKUSGACIYRML-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERUBECESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8931","SCH 900931","SCH-900931","SCH900931","Verubecestat"],"crossReferences":{"drugbank":["DB12285"]},"linkedTargets":{"rows":["ENSG00000186318"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3301622","canonicalSmiles":"CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1","inchiKey":"GYQYAJJFPNQOOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GILTERITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASP-2215","ASP2215","Asp-2215","Gilteritinib"],"crossReferences":{"DailyMed":["gilteritinib%20fumarate"],"drugbank":["DB12141"]},"childChemblIds":["CHEMBL3301603","CHEMBL4524472"],"linkedTargets":{"rows":["ENSG00000167601","ENSG00000122025"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0003086","MONDO_0019457","EFO_0001421","EFO_1000131","EFO_0000222","EFO_0003060","MONDO_0004643"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3301624","canonicalSmiles":"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](C)NC1=O","inchiKey":"HDHDTKMUACZDAA-PHNIDTBTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SETMELANOTIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BIM-22493","RM-493","Setmelanotide"],"crossReferences":{"drugbank":["DB11700"]},"childChemblIds":["CHEMBL4650273"],"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["HP_0000083","Orphanet_739","EFO_0001074","Orphanet_819","EFO_0001073","Orphanet_110"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for obesity and has 6 investigational indications."}
{"id":"CHEMBL3301845","canonicalSmiles":"CC(CCc1ccc2c(c1)OCO2)NN","inchiKey":"IBWPUTAKVGZXRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAFRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Saphrazine"],"crossReferences":{"drugbank":["DB09253"]},"childChemblIds":["CHEMBL3186177"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545009","drugType":"Small molecule","blackBoxWarning":false,"name":"PBF-509","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pbf-509"],"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545163","canonicalSmiles":"CCNC(=O)[C@H]1CC(n2ccc3c(NC(CC)Cc4sccc4Cl)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"CKQOOYMMAAPDKH-NXKGBEFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMP579","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amp579","RPR-100579"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545171","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05089771","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-05089771"],"linkedTargets":{"rows":["ENSG00000169432"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","Orphanet_1956","EFO_0010072","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545215","canonicalSmiles":"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21","inchiKey":"JCINBYQJBYJGDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-911543","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-911543","JAK2 INHIBITOR BMS-911543"],"crossReferences":{"drugbank":["DB12591"]},"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545295","drugType":"Small molecule","blackBoxWarning":false,"name":"AVE0847","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ave0847"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL356700","canonicalSmiles":"NCC1CCN(CC(=O)Nc2cccc3c2C(=O)c2c-3n[nH]c2C2CCCCC2)CC1","inchiKey":"AITZHKQVQNLKHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL356700","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07618"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL361078","canonicalSmiles":"Oc1ccc2c(-c3cc(Br)c(O)cc3O)noc2c1","inchiKey":"LZACPHWPRDKUPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL361078","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07502"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707206","canonicalSmiles":"O=P([O-])([O-])OC(CO)CO.[Ca+2]","inchiKey":"UHHRFSOMMCWGSO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM GLYCERYLPHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1232903","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium glycerylphosphate"],"crossReferences":{"DrugCentral":["4434"],"drugbank":["DB11264"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707219","canonicalSmiles":"COC(=O)c1ccc(OC(=O)CCCCCCC(=O)NO)cc1","inchiKey":"XDZAHHULFQIBFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMETINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-748492","Remetinostat","SHP-141"],"crossReferences":{"drugbank":["DB14869"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707377","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O","inchiKey":"CKFBRGLGTWAVLG-GOMYTPFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEGESTERONE ACETATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nestorone"],"synonyms":["Elcometrine","ST-1435","Segesterone acetate"],"crossReferences":{"DailyMed":["segesterone%20acetate"],"drugbank":["DB14583"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018."}
{"id":"CHEMBL376408","canonicalSmiles":"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]","inchiKey":"HPLNQCPCUACXLM-PGUFJCEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT 737","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-737","Abt 737","Abt-737"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3775741","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM TETRATHIOMOLYBDATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4301078","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATT-M","ATTM","Ammonium tetrathiomolybdate","NSC-286644","NSC-714598","Tiomolibdate diammonium"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL380888","canonicalSmiles":"Oc1cc(O)c(-c2[nH]ncc2N2CCNCC2)cc1Cl","inchiKey":"RFPHEBUOQYYPDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380888","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL38397","canonicalSmiles":"N[C@@H](CC(C(=O)O)C(=O)O)C(=O)O","inchiKey":"UHBYWPGGCSDKFX-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL38397","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03847"],"chEBI":["41450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL396298","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2","inchiKey":"OSFCMRGOZNQUSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELACRIDAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elacridar","LY-335979","LY335979"],"crossReferences":{"PubChem":["137276063"],"drugbank":["DB04881"]},"childChemblIds":["CHEMBL569424","CHEMBL2074730"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989432","canonicalSmiles":"CC(=O)CC/C=C(/C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C.CC(=O)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C","inchiKey":"DJAHKBBSJCDSOZ-AJLBTXRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPRENONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-0671","Geranylgeranylacetone","Selbex","Teprenone"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3990041","drugType":"Gene","blackBoxWarning":false,"name":"NADOFARAGENE FIRADENOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Instiladrin"],"synonyms":["Nadofaragene firadenovec","rAd-IFN","rAd-IFN-2b"],"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3991432","drugType":"Unknown","blackBoxWarning":false,"name":"LUTETIUM DOTATATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["lutetium%20dotatate%20lu-177"]},"childChemblIds":["CHEMBL3989924"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["MONDO_0002120","EFO_1001901","MONDO_0024503","Orphanet_2495","EFO_0000305","EFO_0000621","EFO_1000045"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neuroendocrine neoplasm and pancreatic neuroendocrine tumor and has 5 investigational indications."}
{"id":"CHEMBL423","canonicalSmiles":"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1","inchiKey":"NWIUTZDMDHAVTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAXOLOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betoptic","Betoptic susp"],"synonyms":["ALO-140102 FREE BASE","Betaxolol","Betoptic","Kerledex","Kerlone","SL-7521210 FREE BASE"],"crossReferences":{"DailyMed":["betaxolol%20hydrochloride"],"PubChem":["144203642","170465448","90341580"],"Wikipedia":["Betaxolol"],"drugbank":["DB00195"],"chEBI":["3082"]},"childChemblIds":["CHEMBL1691"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000319","EFO_0000516","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 2 investigational indications."}
{"id":"CHEMBL4297183","canonicalSmiles":"CN1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1","inchiKey":"GMPZPHGHNDMRKL-RZDIXWSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALOVAPTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balovaptan","RG-7314","RG7314","RO-5285119","RO5285119","Rg7314"],"crossReferences":{"drugbank":["DB14823"]},"linkedTargets":{"rows":["ENSG00000166148"],"count":1},"linkedDiseases":{"rows":["EFO_0003756"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297293","canonicalSmiles":"Clc1ccc(-c2nn(Cc3ccccc3)c3c2CCNCC3)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"DIQZMBPDLFAJLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-18038683","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4205783","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-18038683"],"linkedTargets":{"rows":["ENSG00000148680"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002009"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297416","canonicalSmiles":"Cn1nccc1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1","inchiKey":"DVNQWYLVSNPCJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-4191834","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04191834","Pf-4191834"],"crossReferences":{"drugbank":["DB11645"]},"linkedTargets":{"rows":["ENSG00000012779"],"count":1},"linkedDiseases":{"rows":["EFO_0004616","MONDO_0004979"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297457","canonicalSmiles":"CC(C)(O)c1cccn2c(C3(c4ccc(Cl)cc4)CC3)nnc12.Cl","inchiKey":"MQBBSMNIRWXALO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-823778","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4301600","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-823778","Bms-823778"],"linkedTargets":{"rows":["ENSG00000117594"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","MONDO_0005148","Orphanet_309005","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297481","canonicalSmiles":"Cn1ncc2cc(-c3cc(CCC(=O)O)cc(N)c3OC3Cc4ccccc4C3)ccc21","inchiKey":"ULNYPYSSPODXCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AK-106","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-106","AK106","AK106-001616","Ak-106","Ak106-001616"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297555","drugType":"Unknown","blackBoxWarning":false,"name":"RESIMMUNE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-dmdt390-bisfv(ucht1)","LAX-699","Resimmune"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297722","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CEMDISIRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-62643","AD-62643 FREE ACID","ALN-62643","ALN-62643 FREE ACID","Cemdisiran","Cemdisiran sodium"],"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["Orphanet_2134","EFO_0004194","EFO_0004991","Orphanet_447"],"count":4},"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297725","drugType":"Unknown","blackBoxWarning":false,"name":"CHLORINE DIOXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorine dioxide","Chlorine peroxide"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297930","drugType":"Unknown","blackBoxWarning":false,"name":"CYC-065","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyc-065","Cyc065","Fadraciclib"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298054","drugType":"Unknown","blackBoxWarning":false,"name":"STEM BROMELAIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromelain stem bromelain","Debrase","Ec 3.4.22.32","Escharex","Nexobrid","Pineapple stem bromelain","Stem bromelain"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL431210","canonicalSmiles":"CCCC[C@H](CN(O)C=O)C(=O)N[C@H](C(=O)N(C)C)C(C)(C)C","inchiKey":"AVDLWYHBABSSHC-CHWSQXEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BB-3497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-3497"],"crossReferences":{"drugbank":["DB04368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL435966","canonicalSmiles":"O=[N+]([O-])c1cncn1CCN1CCOCC1","inchiKey":"MDJFHRLTPRPZLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIMORAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Naxogin 500"],"synonyms":["K-1900","NSC-107524","Naxogin","Nimorazole"],"crossReferences":{"PubChem":["170466578","92764328"],"drugbank":["DB12172"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL446061","canonicalSmiles":"OCCN(CCO)CCO","inchiKey":"GSEJCLTVZPLZKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROLAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mobisyl [as salicylate]","Xerumenex"],"synonyms":["NSC-36718","Triethanolamine","Trolamine"],"crossReferences":{"PubChem":["144206717","144209260","144210845","26754496","29215347"],"Wikipedia":["Triethanolamine"],"drugbank":["DB13747"],"chEBI":["28621"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for skin ulcer."}
{"id":"CHEMBL44884","canonicalSmiles":"CC[C@@H](CO)NCCN[C@@H](CC)CO","inchiKey":"AEUTYOVWOVBAKS-UWVGGRQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMBUTOL","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ethambutol"],"crossReferences":{"DailyMed":["ethambutol%20hydrochloride"],"TG-GATEs":["83"],"Wikipedia":["Ethambutol"],"drugbank":["DB00330"],"chEBI":["4877"]},"childChemblIds":["CHEMBL1788373","CHEMBL3140361","CHEMBL1628240"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for pulmonary tuberculosis and tuberculosis and has 8 investigational indications."}
{"id":"CHEMBL4594363","drugType":"Unknown","blackBoxWarning":false,"name":"IRGD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEND-1","Cend-1","Irgd"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594493","drugType":"Unknown","blackBoxWarning":false,"name":"SARS-COV","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sars-cov"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594526","drugType":"Antibody","blackBoxWarning":false,"name":"TOSATOXUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-301","AR301","Ar-301","KBSA-301","KBSA301","Kbsa301","Tosatoxumab"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594591","drugType":"Unknown","blackBoxWarning":false,"name":"REGN-1400","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-1400","REGN1400","Regn-1400","Regn1400"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594597","drugType":"Unknown","blackBoxWarning":false,"name":"REGN-5678","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-5678","REGN5678","Regn-5678","Regn5678"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650516","drugType":"Antibody","blackBoxWarning":false,"name":"FINOTONLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Finotonlimab","SCT-I10A","Sct-i10a"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL480329","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C[C@H]1O","inchiKey":"NLIHPCYXRYQPSD-BAJZRUMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3'-dATP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-dATP"],"crossReferences":{"drugbank":["DB01860"],"chEBI":["52316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485696","canonicalSmiles":"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(C)n1","inchiKey":"YZMCKZRAOLZXAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfaisodimidine","Sulfisomidine","Sulfisomidine sodium","Sulphasomidine"],"crossReferences":{"PubChem":["144205683","170465986"],"Wikipedia":["Sulfisomidine"],"drugbank":["DB13283"],"chEBI":["32166"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL493062","canonicalSmiles":"Oc1c(Br)cc(-c2ccccc2)cc1Br","inchiKey":"SKQRVOXIIAXXEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL493062","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89854824"],"drugbank":["DB08102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL508583","canonicalSmiles":"CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCNCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O","inchiKey":"WUJVPODXELZABP-FWJXURDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRODUSQUEMINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MSI-1436","Trodusquemine"],"crossReferences":{"drugbank":["DB06333"]},"childChemblIds":["CHEMBL2028167","CHEMBL2386602"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL509101","canonicalSmiles":"O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O","inchiKey":"OBSFXHDOLBYWRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL509101","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006560"],"drugbank":["DB06896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL514215","canonicalSmiles":"COc1ccc(-c2c(C#N)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)cc1","inchiKey":"MCNQUWLLXZZZAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JHU-75528","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL476413"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL519364","canonicalSmiles":"COc1ccc2c(=O)c(C)c(-c3ccccc3)oc2c1CN(C)C","inchiKey":"ZXFQRFXLFWWKLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMEFLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimefline","NSC-169869"],"crossReferences":{"PubChem":["442471","50125807"],"drugbank":["DB13482"]},"childChemblIds":["CHEMBL1203969"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL522891","canonicalSmiles":"O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1","inchiKey":"FPKSFXFWECAIBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522891","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08066"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559401","canonicalSmiles":"Cc1ccc(C(=O)NC2CC2)cc1Nc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F","inchiKey":"WMEYCLAVMZKZCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL559401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08349"],"chEBI":["82714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590799","canonicalSmiles":"CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1","inchiKey":"XASIMHXSUQUHLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camostat"],"crossReferences":{"PubChem":["174006694","50112779"],"Wikipedia":["Camostat"],"drugbank":["DB13729"]},"childChemblIds":["CHEMBL85164"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL609109","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1","inchiKey":"VZYCZNZBPPHOFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPROPERAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thioproperazine"],"crossReferences":{"Wikipedia":["Thioproperazine"],"drugbank":["DB01622"],"chEBI":["59120"]},"childChemblIds":["CHEMBL1481539","CHEMBL1406487"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL64676","canonicalSmiles":"CC(C)COc1cccc(-c2nc3cc(C(=N)N)ccc3[nH]2)c1O","inchiKey":"HSHVHNIOQTZSOQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL64676","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04470"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL688","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"IVLVTNPOHDFFCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENTANYL CITRATE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL596","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abstral","Actiq","Fentanyl","Fentanyl citrate","Fentanyl citrate preservative free","Fentora","Lazanda","Onsolis","Sublimaze","Sublimaze preservative free","Thalamonal"],"synonyms":["Fentanyl buccal","Fentanyl citrate","Fentanyl citrate cii","Instanyl","Kw-2246","Leptanal","MCN-JR-4263-49","R-4263"],"crossReferences":{"DailyMed":["fentanyl%20citrate"],"chEBI":["31602"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0002094","EFO_0009508","EFO_1001139","HP_0012532","EFO_0003843","EFO_0000311","EFO_0000546","EFO_0009727","HP_0100543","EFO_0003841","HP_0002045","EFO_0004244","HP_0003419","EFO_0000341"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for pain and cancer and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL705","canonicalSmiles":"CC1=C(/C=C/C(C)=C\\C=C\\C(C)=C\\C(=O)O)C(C)(C)CCC1","inchiKey":"SHGAZHPCJJPHSC-ZVCIMWCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALITRETINOIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Panretin","Toctino"],"synonyms":["9-cis retinoic acid","9-cis-retinoic acid","AGN 192013","AGN-192013","ALRT-1057","ALRT1057","Alitretinoin","BAL-4079","LG-100057","LG100057","LGD-1057","LGD1057","NSC-659772","Panretin","Retinoic acid 9-cis-form"],"crossReferences":{"DailyMed":["alitretinoin"],"PubChem":["144212512","26755228","26755229","26755230"],"Wikipedia":["Alitretinoin"],"drugbank":["DB00523"],"chEBI":["50648"]},"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819","ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":6},"linkedDiseases":{"rows":["EFO_0003834","EFO_0000616","HP_0000964","MONDO_0007254","EFO_0000676","Orphanet_3389","EFO_0000274","EFO_1000726","EFO_1000706"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for neoplasm and eczema and has 5 investigational indications."}
{"id":"CHEMBL7492","canonicalSmiles":"COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1","inchiKey":"VJXSSYDSOJBUAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRITREXIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BW-301U","Bw 301u","Bw-301u","Piritrexim","TCMDC-137235"],"crossReferences":{"drugbank":["DB03695"]},"childChemblIds":["CHEMBL1712863"],"linkedTargets":{"rows":["ENSG00000228716"],"count":1},"linkedDiseases":{"rows":["MONDO_0004192","MONDO_0020654","MONDO_0001187"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL84242","canonicalSmiles":"OC(O)(C(F)(F)F)C(F)(F)F","inchiKey":"AKVXSYUWYXOLMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL84242","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02922"]},"childChemblIds":["CHEMBL1989577"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL8642","canonicalSmiles":"COc1ccc(OC)c(CC(C)N)c1","inchiKey":"LATVFYDIBMDBSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL8642","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01465"]},"childChemblIds":["CHEMBL557773"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
